Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/1991
12/31/1991CA1293840C Renin inhibiting polypeptide analogs and intermediates
12/27/1991EP0462627A1 Antigens and peptides of lav.
12/27/1991EP0462531A2 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain
12/27/1991EP0462229A1 Chemically modified cd4 peptide fragments having anti-retroviral properties
12/27/1991EP0462184A1 Method of treating viral infections using lfa-1
12/26/1991WO1992000318A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
12/26/1991WO1991019743A2 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS
12/26/1991WO1991019737A1 Method of making peptides
12/26/1991WO1991019734A2 Thrombin inhibitors based on the amino acid sequence of hirudin
12/26/1991WO1991019512A1 Antimicrobial peptides
12/26/1991CA2084992A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
12/24/1991US5075224 Prepro-LHRH C-terminal peptide DNA
12/19/1991WO1991019802A1 Novel bacteriocin from a strain of lactococcus lactis subsp. cremoris
12/19/1991WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use
12/19/1991CA2085580A1 Bacteriocin from a strain of lactococcus lactis subsp. cremoris
12/19/1991CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use
12/18/1991EP0462065A2 New signal sequences
12/18/1991EP0461707A2 Peptide oxytocin antagonists
12/18/1991EP0461696A1 Crystalline polypeptides with corticotropic activity
12/18/1991EP0461193A1 Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits.
12/17/1991US5073624 Therapeutic decapeptides
12/16/1991WO1991019805A1 A novel vector to produce biologically important peptides
12/16/1991CA2084678A1 Vector to produce biologically important peptides
12/16/1991CA2044476A1 Signal sequences for targeting a protein into a plant vacuole
12/15/1991WO1991019735A1 Libraries of modified peptides with protease resistance
12/15/1991CA2085118A1 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
12/14/1991WO1991019745A1 Chimeric toxins with improved inter-domain geometry
12/14/1991CA2083487A1 Chimeric toxins with improved inter-domain geometry
12/14/1991CA2043497A1 Crystalline polypeptides
12/12/1991WO1991019001A1 Immunodiagnostic assay for rheumatoid arthritis
12/12/1991WO1991018992A2 Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen
12/12/1991WO1991018619A1 Apo ai polypeptides, antibodies, and immunoassays
12/12/1991WO1991018512A1 Method of inducing plant defense mechanisms
12/12/1991WO1991015512A3 Hiv envelope polypeptides
12/12/1991CA2082529A1 Immunodiagnostic assay for rheumatoid arthritis
12/12/1991CA2043861A1 Peptide oxytocin antagonists
12/11/1991EP0460882A2 Lipopeptide deacylase
12/11/1991EP0460446A1 Coupling agent for peptide synthesis
12/11/1991EP0460072A1 Human elastase inhibitor
12/10/1991US5071963 Interferon-induced human (2'-5') oligo a synthetase
12/10/1991US5071955 Octopeptide exhibiting antimypertensive activity
12/10/1991US5071954 Used for immunization of animals and purification of specific antibodies; purity
12/10/1991US5071836 Competitive gonadoliberin antagonists
12/10/1991US5071835 Ribonucleotide reductase inhibitors
12/10/1991CA1292962C Optimized nutrient conditions for producing microorganism secondary metabolites
12/07/1991CA2044028A1 Cyclosporine metabolites
12/04/1991EP0459564A2 Process for reduction of echinocandin type cyclohexapeptide compounds
12/04/1991EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
12/03/1991US5070187 Pharmacologically effective antagonists of arginine-vasopressin
12/03/1991US5070074 Insulinase inhibitors
12/03/1991CA1292842C Bradykinin antagonist peptides
12/03/1991CA1292841C Peptide derivatives, their production and use
12/03/1991CA1292839C Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
12/02/1991WO1991018980A1 Compositions and methods for identifying biologically active molecules
12/02/1991WO1991018866A2 1,4-diamino-2,3-dihydroxybutanes
12/02/1991CA2084307A1 Compositions and methods for identifying biologically active molecules
12/02/1991CA2084087A1 1,4-diamino 2,3-dihydroxy butanes
12/01/1991WO1991019197A1 Immunochemical localization of heparanase in mouse and human melanomas
12/01/1991CA2083052A1 Immunochemical localization of heparanase in mouse and human melanomas
11/1991
11/30/1991CA2043378A1 Process for reduction of certain cyclohexapeptide compounds
11/28/1991WO1991018294A1 Synthetic peptides of human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunossay for diagnostic purposes
11/28/1991WO1991018098A1 Bone and cartilage inductive proteins
11/28/1991WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan
11/28/1991WO1991018013A1 Synthetic senescent cell antigen
11/28/1991WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same
11/28/1991WO1991017760A1 Composition of and treatment with biologically active peptides having d-amino acid residues
11/28/1991WO1991008478A3 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
11/28/1991CA2083150A1 Synthetic senescent cell antigen
11/28/1991CA2082941A1 Bone and cartilage inductive proteins
11/27/1991EP0458475A2 Transpeptidation reagent and method
11/26/1991US5068314 Lipopolysaccharide-binding polypeptide
11/26/1991US5068222 Polypeptides for treatment of cancer
11/21/1991EP0456790A1 Antibody variable domain conjugates.
11/21/1991EP0456758A1 Anaphylatoxin-receptor ligands
11/21/1991EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants
11/21/1991EP0413766A4 Synthetic peptides for arterial imaging
11/19/1991CA1292344C Peptides and therapeutic applications thereof
11/19/1991CA1292343C Di- and tri-peptidal renin inhibitors
11/16/1991WO1991017823A1 Method and apparatus for biopolymer synthesis
11/15/1991CA2042468A1 Compositions of and treatment with biologically active peptides having d-amino acid residues
11/14/1991WO1991017181A1 Cyclized and linear therapeutic peptides
11/14/1991WO1991016919A1 Synthetic peptides for arterial imaging
11/14/1991CA2081890A1 Cyclized and linear therapeutic peptides
11/14/1991CA2080493A1 Synthetic peptides for arterial imaging
11/13/1991EP0456197A1 Seroreactive epitopes from proteins of human papilloma virus (HPV) 18
11/13/1991EP0456152A2 Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors
11/13/1991EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides.
11/13/1991EP0412115A4 Hybrid peptides and methods of their use
11/13/1991EP0180596B1 Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelet with vessel walls
11/13/1991CN1056105A Peptides with bradykinin-antagonistic action
11/12/1991US5064939 Cyclic gnrh antagonists
11/12/1991CA2082658A1 Synthetic peptides of human papillomaviruses 1,5,6,8,11,16,18,31,33 and 56, useful in immunoassay for diagnostic purposes
11/11/1991WO1991017258A1 Inhibitors of factor xii activation and applications thereof
11/11/1991CA2082643A1 Inhibitors of factor xii activation and applications thereof
11/06/1991EP0455133A2 Peptide antagonists of bradykinin
11/05/1991US5063206 Compositions having use as treatment of neuropsychiatric deficits
11/05/1991US5063150 Immunology
10/1991
10/31/1991WO1991016355A1 Method for increasing blood-brain barrier permeability
10/31/1991WO1991016343A1 (hyp 9) lhrh, its derivatives or fragments, production method and uses as a drug or in an assay
10/31/1991WO1991016340A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 423